Outcomes of the addition of oral administration of curcumin-phospholipid to hyaluronic acid-based tear substitute for the treatment of dry eye disease

MLA

Massimiliano Borselli, et al. “Outcomes of the Addition of Oral Administration of Curcumin-Phospholipid to Hyaluronic Acid-Based Tear Substitute for the Treatment of Dry Eye Disease.” Frontiers in Ophthalmology, vol. 3, Oct. 2023. EBSCOhost, https://doi.org/10.3389/fopht.2023.1236525.

APA

Massimiliano Borselli, Fausto F. Ferrari, Pietro Bianchi, Costanza Rossi, Giovanna Carnovale Scalzo, Domenica Mangialavori, Vincenzo Scorcia, & Giuseppe Giannaccare. (2023). Outcomes of the addition of oral administration of curcumin-phospholipid to hyaluronic acid-based tear substitute for the treatment of dry eye disease. Frontiers in Ophthalmology, 3. https://doi.org/10.3389/fopht.2023.1236525

Chicago

Massimiliano Borselli, Fausto F. Ferrari, Pietro Bianchi, Costanza Rossi, Giovanna Carnovale Scalzo, Domenica Mangialavori, Vincenzo Scorcia, and Giuseppe Giannaccare. 2023. “Outcomes of the Addition of Oral Administration of Curcumin-Phospholipid to Hyaluronic Acid-Based Tear Substitute for the Treatment of Dry Eye Disease.” Frontiers in Ophthalmology 3 (October). doi:10.3389/fopht.2023.1236525.